Does non-attenuation correction influence lesion detectability in FDG PET of thyroid cancer.

被引:0
|
作者
Helal, BO
Trebossen, R
Pointurier, I
Delbot, T
Leperse, V
Syrota, A
机构
[1] Hop Antoine Beclere, Clamart, France
[2] CEA, Serv Hosp Frederic Joliot, F-91406 Orsay, France
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1284
引用
收藏
页码:319P / 319P
页数:1
相关论文
共 50 条
  • [41] Clinical usefulness of F-18 FDG PET/CT as screening test in healthy population: Correlation of PET/CT findings between thyroid lesion and thyroid cancer
    Kim, Jeong Hun
    Lim, Seok Tae
    Han, Yeon-hee
    Yun, Kuk-no
    Moon, Eun-Ha
    Kim, Dong Wook
    Jeong, Hwan-Jeong
    Sohn, Myung-Hee
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [42] A comparison of reconstruction algorithms with FDG PET. Iterative reconstruction segmented attenuation correction (IRSAC) allows greater detectability than filtered back projection (FBP).
    Akhurst, T
    Erdi, Y
    Colsher, J
    Crandall, P
    MacApinlac, H
    Humm, J
    Yeung, H
    Larson, SM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1027 - 1027
  • [43] Pretreatment prediction of prognosis by FDG-PET in patients with non-small cell lung cancer.
    Sasaki, M
    Kuwabara, Y
    Koga, H
    Nakagawa, M
    Hayashi, K
    Kaneko, K
    Chen, T
    Masuda, K
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 301P - 301P
  • [44] ROC and localization ROC analyses of lesion detection in whole-body FDG PET: Effects of acquisition mode, attenuation correction and reconstruction algorithm
    Farquhar, TH
    Llacer, J
    Hoh, CK
    Czernin, J
    Gambhir, SS
    Seltzer, MA
    Silverman, DHS
    Qi, JY
    Hsu, CH
    Hoffman, EJ
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (12) : 2043 - 2052
  • [45] What is the impact of 18F-FDG PET/CT in the management of iodine positive metastatic differentiated thyroid cancer.
    Alsalloum, Riyadh
    Tuli, Mahmoud
    Abouzied, Mohei
    Almuhaideb, Ahmad
    Al-Sugair, Abdulaziz
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [46] Concurrent 131I whole body scan and FDG whole body PET study of recurrent thyroid cancer.
    Chu, LS
    Liu, RS
    Sun, CM
    Chang, CP
    Lee, CH
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 9P - 9P
  • [47] Influence on patients' management by whole-body F-18 FDG PET for preoperative staging of non small cell lung cancer.
    Baum, RP
    Rust, M
    Adams, S
    Strassmann, G
    Berkefeld, J
    Wagner, R
    Hertel, A
    Hor, G
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 473 - 473
  • [48] Incidental thyroid cancer detected by 18 F-FDG PET: does it have different clinicopathological features
    Pak, Kyoungjune
    Cheon, Gi Jeong
    Lee, Kyu Eun
    Park, Young Joo
    Choi, Hoon Sung
    Min, Hye Sook
    Kang, Keon Wook
    Chung, June-Key
    Kim, Euishin E.
    Lee, Dong Soo
    NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (05) : 453 - 458
  • [49] Reproducibility of Semi-quantitative Parameters in FDG-PET Using Two Different PET Scanners: Influence of Attenuation Correction Method and Examination Interval
    Tomohito Kamibayashi
    Tatsuro Tsuchida
    Yoshiki Demura
    Tetsuya Tsujikawa
    Hidehiko Okazawa
    Takashi Kudoh
    Hirohiko Kimura
    Molecular Imaging and Biology, 2008, 10 : 162 - 166
  • [50] Reproducibility of semi-quantitative parameters in FDG-PET using two different PET scanners: Influence of attenuation correction method and examination interval
    Kamibayashi, Tomohito
    Tsuchida, Tatsuro
    Demura, Yoshiki
    Tsujikawa, Tetsuya
    Okazawa, Hidehiko
    Kudoh, Takashi
    Kimura, Hirohiko
    MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (03) : 162 - 166